Cornerstone Planning Group’s iRadimed IRMD Stock Holding History

Cornerstone Planning Group’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.1K	Buy	154 +1	+0.7%	+$100	﹤0.01%	820
2025 Q4	$15K	Buy	153 +15	+11%	+$1.29K	﹤0.01%	673
2025 Q3	$10.5K	Buy	+138	New	+$9.2K	﹤0.01%	766
2025 Q2	–	Sell	-62	Closed	-$3.27K	–	1611
2025 Q1	$3.27K	Buy	+62	New	+$3.48K	﹤0.01%	847
2024 Q3	–	Sell	-15	Closed	-$664	–	1329
2024 Q2	$664	Buy	+15	New	+$638	﹤0.01%	1034

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cornerstone Planning Group's IRMD Position: Q1 2026 in Review

Cornerstone Planning Group increased its iRadimed (IRMD) stake by 0.65% in Q1 2026, buying an estimated $100 and bringing the position to 154 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #820.

Cornerstone Planning Group first reported a position in IRMD in Q2 2024 and has held it in 5 quarters since. The position peaked at $15K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Cornerstone Planning Group held 154 shares of iRadimed worth $13.1K as of Q1 2026.
Cornerstone Planning Group bought 1 iRadimed share in Q1 2026, an estimated $100.
iRadimed made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q1 2026, its #820 holding.
Cornerstone Planning Group first reported a position in iRadimed in Q2 2024 and has held it in 5 quarters since.
Cornerstone Planning Group's iRadimed position peaked at $15K in Q4 2025.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Cornerstone Planning Group's 13F filing for Q1 2026, filed 6 May 2026.